Encyclopedia

Inosine

Also found in: Dictionary, Medical, Wikipedia.
(redirected from Inosine monophosphate)

inosine

[′in·ə‚sēn]
(biochemistry)
C10H12N4O5 A compound occurring in muscle; a hydrolysis product of inosinic acid.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
The following article is from The Great Soviet Encyclopedia (1979). It might be outdated or ideologically biased.

Inosine

 

(hypoxanthine riboside), a nucleoside consisting of the nitride purine base hypoxanthine and the carbohydrate ribose. Inosine is the intermediate product of nucleic acid metabolism. It is formed in the organism during the deamination of adenosine and also by synthesis from a free base according to the reaction hypoxanthine + ribose- 1 -phosphate ⇆ inosine + phosphate. This reversible reaction is catalyzed by the enzyme nucleoside phosphorylase.

The Great Soviet Encyclopedia, 3rd Edition (1970-1979). © 2010 The Gale Group, Inc. All rights reserved.
Mentioned in
References in periodicals archive
Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.
Effect of sea buckthorn leaves on inosine monophosphate and adenylocuccinatelyase gene expression in broilers during heat stress.
(3) Nonstandard abbreviations: AZA, azathioprine; TPMT, thiopurine methyltransferase; ITP, inosine triphosphate; ITPA, inosine triphosphate pyrophosphohydrolase; IMP, inosine monophosphate; DTT, dithiothreitol; and CI, confidence interval.
Muscle inosine monophosphate (IMP) content is an indicator meat flavor and adenylosuccinatelyase (ADSL) is a key enzymes regulating IMP synthesis.
Inosine triphosphatase (ITPA; EC 3.6.1.19) catalyzes the hydrolysis of ITP to inosine monophosphate, thereby recycling purines that might otherwise be trapped in the form of ITP (1, 2).
A study by Kazeniac (1961) indicated that inosine monophosphate (IMP) produced a major contribution to mouth satisfaction and had the effect of intensifying the flavor effects of other compounds.
In vitro investigations with recombinant human inosine monophosphate dehydrogenase II-and phytohemagglutinin A-stimulated human peripheral blood mononuclear cells support the concept that the free fraction of MPA is the pharmacologically active form of the drug (6).
Various approaches have been proposed for the pharmacodynamic (PD) monitoring of immunosuppressants: One is evaluation of the activity of the specific target enzyme, such as calcineurin activity (CNA) for cyclosporin A (CsA) and tacrolimus (TRL) (3-5), inosine monophosphate dehydrogenase for MMF (6-8), and P70S6 kinase activity for sirolimus (1, 9).
MMF is rapidly metabolized in vivo to its active constituent, mycophenolic acid (MPA), a reversible, noncompetitive inhibitor of inosine monophosphate dehydrogenase.
Intracellularly, MP is converted by hypoxanthine guanine phosphorybosyltransferase into thioinosine monophosphate (TIMP) and subsequently into thioguanosine monophosphate by a two-step process involving inosine monophosphate dehydrogenase and guanosine monophosphate synthetase (2).
MMF targets the de novo purine biosynthesis pathway by noncompetitive inhibition of inosine monophosphate dehydrogenase, acting against the proliferation of T and B lymphocytes (1).
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.